In this study, we compared serum TIMP-1 levels in 140 prostate cancer patients in various disease stages and 16 males without known evidence of prostate cancer including patients with benign prostatic hyperplasia by sandwich ELISA. The gene discussed is TIMP1; the disease is benign prostatic hyperplasia.